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Abstract: This study investigated the associations of muscular fitness and various indicators
of body fatness with cardio-metabolic risk factors and determined the muscular strength and
body fatness thresholds for detecting a high risk of cardio-metabolic dysfunction in young adults.
A cross-sectional study was conducted on 1798 collegiate students (61.5% females, mean age
20.5 years). Muscular fitness was determined by using a handgrip strength test and normalized
grip strength (NGS = handgrip (kg)/body mass (kg)). Body mass index (BMI), waist circumference
(WC), percentage of fat mass (BF%), fat-mass index (FMI), and waist-to-height ratio (WHR) were
also included as body fatness measurements. A high cardio-metabolic risk cluster was derived by
assessing triglycerides, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL)
cholesterol, fasting glucose, and blood pressure. Logistic regression models showed that men and
women with lower NGS had an increased cardio-metabolic risk odds ratio (OR) = 1.8, 95% confidence
interval (CI) 1.1 to 2.9, p = 0.006, and OR = 1.6, 95% CI 1.0 to 2.5, p = 0.036, respectively). In both
sexes, higher levels of all fatness parameters were also associated with increased cardio-metabolic
risk (p < 0.001). In both men and women, high FMI had the highest OR for clustered risk (OR = 4.7,
95% CI 2.6 to 8.4, and OR = 7.3, 95% CI 3.4 to 9.7, p < 0.001, respectively). Combined analysis showed
that unfitness (lower NGS) and high fat had the highest OR for WC and FMI in men and women,
respectively (OR = 5.5, 95% CI 2.6 to 11.4, OR = 7.7, 95% CI 2.3 to 15.8, p < 0.01). Muscular strength
and body fatness are independently and jointly associated with increased cardiometabolic risk in
young adults, which suggests that both are predictor variables for this.
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1. Introduction
Metabolic and cardiovascular disturbances such as visceral adiposity, dyslipidemia, elevated
blood pressure, and impaired insulin metabolism have been identified as risk factors for cardiovascular
disease (CVD) and all-cause and CVD mortality. The fastest rise in CVD mortality has been observed
in low-income and middle-income countries [1]. In Colombia, national overweight and obesity
trends have been adversely affected by Westernised dietary habits and chronic physical inactivity [2].
Consequently, adiposity excess is a key contributor to the clustering of unfavorable cardio-metabolic
risk factor levels in youth populations [3].
Muscular strength, as determined with a handgrip dynamometer, is becoming increasingly
recognized as a predictor of all-cause mortality in healthy populations [4]. In fact, consistent evidence
supports the idea that muscular fitness is a predictor of cardio-metabolic diseases and mortality [5,6].
In recent years, research has shown that muscle strength is negatively associated with metabolic
syndrome in young adults [7–11]. Additionally, in a prospective study (20-year follow up of young
adults), Fraser et al. [12] showed that those in the lowest third tertile for strength were independently
associated with adult metabolic syndrome. The physiological pathways relating muscular fitness with
cardio-metabolic risk place muscle mass as the main driver of this relationship since skeletal muscle is
the principal site of insulin-mediated glucose uptake, which is closely related to muscular fitness [13].
On the other hand, there is growing evidence supporting the hypothesis that both general and
central adiposity have a causal effect on cardiovascular events [14–18]. Fatness is defined as excess
fat in places classically associated with adipose tissue storage and may contribute to inflammation
and insulin resistance [19]. Both situations are related to disorders of other organs and tissues, e.g.,
abdominal fat and skeletal muscles [20]. These organs and tissues play a central role in glucose and
lipid metabolism [21]. Changed body composition arising from obesity-related reduced skeletal muscle
mass and increased visceral fat, known as ‘sarcopenic obesity’, aggravates insulin resistance and, thus,
seems to be closely related to the onset and progression of CVD mediated by the abnormal metabolism
of glucose and lipids [22]. In longitudinal data, childhood waist circumference (WC) has been reported
as one of the strongest predictors of metabolic syndrome in adulthood [23].
A better understanding of how muscular fitness and fatness relate to other cardio-metabolic
risk factors has the potential to improve health promotion efforts. To date, there is limited evidence
on the influence of muscle strength and single and combined fatness measurements on clustered
cardio-metabolic risk in young adults.
Accordingly, the aim of this study was two-fold: (i) to investigate the associations of muscular
fitness and various body fatness indicators with cardio-metabolic risk factors and (ii) to determine
the cut-off muscular strength and body fatness levels for detecting a high risk of cardio-metabolic
dysfunction in Colombian university students.
2. Methods
2.1. Study Design and Sample Population
We used secondary data from the cross-sectional Fuprecol Study adolescents and young adults,
which investigated the association between muscular strength and metabolic risk factors in Colombian
collegiate students. We recently published a complete description of the Fuprecol study’s design and
methods and the primary outcomes for our current cohort [24]. The students were enrolled in public or
private universities from three distinct areas of Colombia: the capital district of Bogota (Cundinamarca),
Tunja (Boyacá), and Santiago de Cali (Valle del Cauca). Of this group, 1798 collegiate students (61.5%
females) had valid data for body composition and all the components of the cardio-metabolic variables.
The Committee for Human Research Ethics of Universidad Manuela Beltrán (UMB Code Nº
01-1802-2013) approved the study, which complied with Colombian laws (Declaration and Resolution
8430 of the Ministry of Health of Colombia, 1993) and the principles of the Declaration of Helsinki.
All participants and their parents/guardians provided their written, informed consent.
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2.2. Muscular Strength
We used a handgrip strength test (T.K.K. 5001, Grip-A, Takei, Japan) adjusted for each participant
by sex and hand size as muscular fitness “proxy”. The participants were instructed to stand with their
arms completely extended, squeezing the handgrip gradually and continuously as hard as they could
for at least 2 s. The test was performed twice, alternating hands between tests. A 90-s rest period
was provided between trials. The best score for each hand was recorded in kilograms. The handgrip
score (kg) was calculated as the average of the left and right hands and then expressed per kilogram
of body weight. The reproducibility of our data was R = 0.96. Intra-rater reliability was assessed
by determining the intra-class correlation coefficient (0.98, CI 95% 0.97–0.99, n = 20, median age =
22.8 ± 1.4 years, 66.2 ± 5.4 kg, 1.67 ± 0.1 m, 24.9 ± 3.1 kg/m2). Since there is substantial covariance
between strength capacity and body mass and the link between strength and the proportion of strength
relative to body mass directly mediates both physical function and chronic health, handgrip strength
was normalized as grip strength (NGS) per body mass, i.e., handgrip strength in kg/body mass in kg.
2.3. Body Fatness Examination
Fatness and clinical examinations were carried out between 25 January 2015 and 30 March 2017
by trained personnel and followed standardized routines described in detail elsewhere [24]. Briefly,
fat mass and the fat mass index were measured by using tetrapolar whole body impedance (Tanita
Model BC-420®, TANITA Corporation, Tokyo, Japan). A detailed description of the bioelectrical
impedance analysis (BIA) technique can be found in a previous study [24]. The corresponding
intra-observer technical error (% reliability) of the measurements was 95%. WC (cm) was measured at
the uppermost border of the iliac crest around the abdomen. When this point was not evident, WC
was measured at the midpoint between the last rib and the iliac crest using a metal tape measure
(Lufkin W606PM®, Allers Parsippany, NJ, USA) in accordance with the International Society for the
Advancement of Kinanthropometry guidelines.
Body mass index (BMI) was calculated as (weight/height2) and was classified using the World
Health Organization criteria (normal: 18.5 to 24.9 kg/m2, overweight: 25.0 to 29.9 kg/m2, and obese:
≥30 kg/m2). The waist-to-height ratio (WHR) was expressed as the ratio of WC (in cm) to height
(in cm). For all measurements, the tape was positioned at a level parallel to the floor. The evaluation
process was carried out by a team of professionals (four physical therapy professors) with extensive
experience in anthropometric measurement. In addition, 2% of the sample was measured twice to
ensure the quality of the measurements. The technical error of measurement (TEM) values were less
than 2% for all anthropometric variables.
2.4. Cardio-Metabolic Risk Factors
For blood measurements, the participants were asked to arrive in a fasting state by abstaining
from exercise training, caffeine, nicotine, and alcohol 12 h before the clinical examination and continue
their regular medication routines. Capillary blood samples (40 µL) were collected for determining
serum biochemical parameters including triglycerides, low-density lipoprotein cholesterol (LDL-c),
high-density lipoprotein cholesterol (HDL-c), and fasting glucose by using portable Cardiocheck®
equipment (Mexglobal SA, Parsippany, NJ, USA).
The blood pressure was measured with an automatic monitor (Omrom® HEM 705 CP, Health-care
Co, Kyoto, Japan) following the recommendations of the European Heart Society (on the right arm, with
the participants in a supine position, and after 10 min of rest). During the measurement, the participants
were seated with the arm supported at the level of the heart.
The presence of cardio-metabolic risk factors was defined on the basis of diagnostic criteria
for the metabolic disorders [25]: elevated triglyceride (TG) level (≥150 mg/dL) or pharmacological
treatment for dyslipidemia, reduced HDL cholesterol level (<40 mg/dL in women and <50 mg/dL
in men), or pharmacological treatment for dyslipidemia, elevated blood pressure (systolic ≥ 130 mm
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Hg and/or diastolic ≥ 85 mm Hg) or pharmacological treatment for hypertension, and an elevated
fasting glucose level (≥100 mg/dL) or pharmacological treatment for diabetes. In addition, an elevated
LDL cholesterol level (≥110 mg/dL) or pharmacological treatment for dyslipidemia was considered
in the definition of high cardiometabolic risk, as suggested by the 2013 American College of
Cardiology/American Heart Association guideline [25]. High cardio-metabolic risk was defined
as the presence of two or more of these risk factors. Because WC is strongly correlated with other
indices of fatness, WC was not considered in the definition of high cardio-metabolic risk to avoid
biasing the results against the higher fatness groups, which was suggested by other studies [26,27].
2.5. Covariables
Data on smoking were collected via self-reported questionnaires (number of cigarettes smoked
per day). The smoking status was determined as a non-smoker or quit smoking ≥12 months ago via
personal interviews with the participants [28]. The physically active category was defined as ≥150 min
of moderate activity per week at least three times per week [28]. Food consumption was assessed by
the Kidmed index (Mediterranean Diet Quality Index) was used. The index is based on a 16-questions
self-administered, which sustain the principles of the Mediterranean dietary patterns, as well as, those
that undermine it. In this study, we divided participants into two groups: less or equal to 8 points
(ideal healthy diet), and less or equal to 7 points (non-ideal healthy diet).
2.6. Data Management
Participants were divided into the following groups according to the fatness parameters (BMI,
WC, percentage of fat mass (%BF), fat-mass index (FMI), and WHR) and muscular fitness (fit and
unfit): (i) Unfit and low fat; (ii) unfit and high fat; and (iii) fit and high fat as previously described [13].
2.7. Statistical Analysis
Descriptive statistics were computed and summarized. Continuous variables are reported using
means and standard deviations (SD) and categorical variables are reported using proportions (%).
The t-test was used to compare unadjusted means and the chi-square test (χ2) was used to explore
sex-group differences. Receiver operating characteristic (ROC) curve analysis was used to estimate
the optimal thresholds of NGS, BMI, WC, %BF, FMI, and WHR that best identify individuals with
high cardio-metabolic risk (i.e., ≥2 cardio-metabolic risk factors present) [29]. All combinations of
sensitivity and 1 − specificity that can be realized by incrementally changing the cut-off values of
NGS, BMI, WC, %BF, FMI, and WHR were summarized as the areas under the ROC curves (AUC)
with 95% CIs for each parameter. Optimal thresholds for each variable were estimated by the Youden
Index [30] as the value producing the combination of sensitivity and specificity closest to 1 (i.e., perfect
test). Sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR-), positive
predictive value (PPV), and negative predictive value (NPV) of the CRF were calculated at all possible
cut-points to find the optimal value.
Logistic regression analyses were used to estimate adjusted odds ratios (ORs) and 95% CIs for
having high cardio-metabolic risk, according to independent and combined categories of NGS, BMI,
WC, %BF, FMI, and WHR. All analyses were performed separately for men and women. Statistical
programs MedCalc 16.8.4® (MedCalc software bvba, Ostend, Belgium) and SPSS (IBM software, v.22.0,
SPSS, Inc., Chicago, IL, USA) were used for all analyses and a value of p < 0.05 was considered
statistically significant.
3. Results
3.1. Study Participants
The descriptive characteristics of the participants are shown in Table 1. The mean age of the
sample was 20.5 (3.1) years and there were more women (61.5%) than men (38.5%). The men had
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higher body weights, heights, and WCs than the women (p < 0.001) while the women had higher BF%
and FMI (p < 0.001). Furthermore, systolic and diastolic blood pressures were higher in men than in
women (p < 0.001). For cardio-metabolic parameters, the men had higher TG levels while the women
had higher HDL cholesterol and glucose levels (p < 0.05). The women had a similar metabolic risk
(p = 0.826) and lower physical activity levels than the men (p < 0.001). Lastly, handgrip and NGS were
significantly higher in men than in women (p < 0.001).
Table 1. Characteristics among a sample of college students from Colombia.
Characteristics Men(n = 692)
Women
(n = 1106) p Value
Age (years) 20.5 (3.2) 20.5 (2.9) 0.077
Anthropometric and fatness parameters
Weight (kg) 68.9 (12.2) 58.7 (10.3) <0.001
Height (cm) 172.3 (6.6) 159.0 (5.8) <0.001
WC (cm) 78.2 (9.3) 71.5 (8.0) <0.001
High fat N, (%) * 77 (11.1) 153 (13.8) 0.071
BF% 15.6 (6.5) 27.0 (7.2) 0.002
High fat N, (%) * 58 (8.3) 59 (5.3) 0.018
FMI (kg/m2) 3.8 (2.2) 6.5 (2.7) <0.001
High fat N, (%) * 62 (8.9) 56 (5.1) 0.002
BMI status 23.1 (3.6) 23.2 (3.7) 0.089
High fat N, (%) * 178 (25.6) 296 (26.7) 0.616
WHR (cm) 0.463 (0.05) 0.451 (0.05) <0.001
High fat N, (%) * 123 (17.4) 173 (15.3) 0.216
Blood pressure
Systolic blood pressure (mmHg) 120.2 (12.9) 111.2 (11.1) <0.001
Diastolic blood pressure (mmHg) 74.1 (11.4) 71.7 (9.3) <0.001
Cardio-metabolic parameters
Triglycerides (mg/dL) 93.7 (48.5) 88.5 (45.3) 0.017
LDL cholesterol (mg/dL) 81.0 (26.0) 87.9 (26.1) 0.386
HDL cholesterol (mg/dL) 39.5 (10.6) 43.9 (12.8) <0.001
Glucose (mg/dL) 84.8 (11.9) 86.0 (11.5) 0.010
High metabolic risk N (%) # 253 (36.5) 398 (36.0) 0.826
Life-style
Tobacco (≥10 cigarettes per week) N, (%) * 199 (28.7) 210 (19.0) 0.548
Alcohol (≥1 times per week) N, (%) * 378 (54.6) 430 (38.9) 0.451
Physical activity (>150 min per week) N, (%) * 243 (35.1) 222 (20.1) 0.001
Adherence to a MedDiet (food consumption)
Optimal adherence N, (%) * 76 (11.0) 124 (11.1) 0.241
Muscular strength
Handgrip (kg) 39.4 (7.1) 24.0 (4.9) <0.001
NGS 0.582 (0.11) 0.416 (0.09) <0.001
Continuous variables are reported by using means and standard deviations (SD) and categorical variables are
reported using proportions N, (%) *. The t-test was used to compare unadjusted means and the chi-square test (χ2) *
was used to explore sex-group differences. NGS, normalized grip strength (Handgrip (kg)/body mass (kg)), BMI,
body mass index, WC, waist circumference, BF%, Body fat percentage, FMI, fat mass index, WHR, Waist to height
ratio, LDL, low-density lipoprotein cholesterol, HDL, high-density lipoprotein cholesterol, MedDiet, KIDMED
Mediterranean Diet Quality Index, # High cardio-metabolic risk defined as the presence of at least two abnormalities.
3.2. Association between Fitness and Fatness Parameters with Cardiometabolic Risk Factors
A logistic regression analysis of fitness, fatness parameters, and highly clustered risk after
adjusting by age, alcohol consumption, tobacco use, and dietary intake is shown in Table 2. Men and
women with lower NGS had increased cardio-metabolic risk (OR = 1.8, 95% CI 1.1 to 2.9, p = 0.006,
and OR = 1.6, 95% CI 1.0 to 2.5, p = 0.036, respectively). In both sexes, higher levels of all fatness
parameters (BMI, WC, %BF, FMI, and WHR) were also associated with increased cardio-metabolic
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risk (p < 0.001). Note that, in both men and women, high FMI had the highest OR for clustered risk
(OR = 4.7, 95% CI 2.6 to 8.4, p < 0.001, and OR = 7.3, 95% CI 3.4 to 9.7, p < 0.001, respectively).
Table 2. Associations between fitness and fatness parameters with high cardio-metabolic risk.
Parameter
Men
(n = 692)
Women
(n = 1106)
OR 95% CI p Value OR 95% CI p Value
Low NGS 1.8 1.1–2.9 0.006 1.6 1.0–2.5 0.036
High body mass index 3.4 2.3–4.9 <0.001 3.5 2.4–5.2 <0.001
High waist circumference 4.5 2.7–7.6 <0.001 4.1 2.5–6.5 <0.001
High body fat percentage 4.5 2.4–8.1 <0.001 6.4 3.1–8.1 <0.001
High fat mass index 4.7 2.6–8.4 <0.001 7.3 3.4–9.7 <0.001
High WHR 3.8 2.5–5.9 <0.001 4.0 2.5–6.4 <0.001
NGS, normalized grip strength (Handgrip (kg)/body mass (kg)). WHR, Waist to height ratio. Analysis adjusted by
age, alcohol, tobacco, and food consumption.
To further explore the association of muscular strength and fatness measurements with high
cardio-metabolic risk, the combined effects were examined (Table 3). For all fatness parameters,
the unhealthiest profiles (unfitness and high fat) in both genders were associated with increased
cardio-metabolic risk adjusted for confounding factors (p < 0.001). Unfitness and high fat profiles
had the highest OR for WC in men and for FMI in women (OR = 5.5, 95% CI 2.6 to 11.4, p ≤ 0.001,
and OR = 7.7, 95% CI 2.3 to 15.8, p = 0.001, respectively).
Table 3. Combined effects of muscular fitness and fatness parameters on high cardio-metabolic risk.
Parameter
Men
(n = 692)
Women
(n = 1106)
OR 95% CI p Value OR 95% CI p Value
Body mass index
Unfit and low fat 1.0 0.5–2.1 0.858 0.7 0.2–1.7 0.441
Unfit and high fat 4.6 2.5–8.5 <0.001 3.8 2.1–6.6 <0.001
Fit and high fat 2.9 1.9–4.5 <0.001 3.3 2.1–5.1 <0.001
Fit and low fat 1.0 (Reference) 1.0 (Reference)
Waist circumference
Unfit and low fat 1.0 0.6–1.9 0.763 1.1 0.6–2.0 0.727
Unfit and high fat 5.5 2.6–11.4 <0.001 4.1 2.0–8.1 <0.001
Fit and high fat 3.6 1.7–7.4 0.001 4.1 2.2–7.5 <0.001
Fit and low fat 1.0 (Reference) 1.0 (Reference)
Body fat percentage
Unfit and low fat 1.4 0.8–2.4 0.192 1.1 0.6–1.93 0.655
Unfit and high fat 4.7 2.1–10.7 <0.001 7.4 2.9–18.9 <0.001
Fit and high fat 4.6 1.9–10.9 <0.001 5.3 1.7–16.9 0.004
Fit and low fat 1.0 (Reference) 1.0 (Reference)
Fat mass index
Unfit and low fat 1.2 0.7–2.1 0.435 1.133 0.6–1.94 0.650
Unfit and high fat 4.8 2.3–10.2 <0.001 7.751 2.3–15.8 0.001
Fit and high fat 4.8 1.9–11.9 0.001 7.332 2.8–18.9 <0.001
Fit and low fat 1.0 (Reference) 1.0 (Reference)
WHR
Unfit and low fat 1.1 0.7–1.6 0.661 1.1 0.6–2.3 0.757
Unfit and high fat 4.1 2.1–10.1 <0.001 4.1 2.1–9.1 <0.001
Fit and high fat 2.6 1.6–5.31 <0.001 3.1 2.9–5.1 <0.001
Fit and low fat 1.0 (Reference) 1.0 (Reference)
Analysis adjusted by age, alcohol, tobacco, and food consumption. WHR, Waist to height ratio.
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3.3. Optimal Cut-Off Metabolic Syndrome Screening Value
The ROC curve analyses diagnosing how well fitness and fatness parameters identify high
cardio-metabolic risk in men and women are presented in Table 4. The ROC analyses showed that
fitness and fatness parameters could be used to identify highly clustered cardio-metabolic risk in
young adults.
For men, the NGS cut-off value of 0.56 provided a sensitivity of 56% and a specificity of 65%.
In fatness parameters, the BMI cut-off value of 24.7 kg/m2 provided a sensitivity of 43% and a
specificity of 81% and the WC cut-off value of 83.0 cm provided a sensitivity of 39% and a specificity
of 85%. The ROC curve for BF% was also obtained by using a cut-off value of 19.2%, a sensitivity of
42%, and a specificity of 83%. Furthermore, the FMI cut-off value of 4.78 kg/m2 provided a sensitivity
of 42% and a specificity of 83% and the WHR cut-off value of 0.49 provided a sensitivity of 32% and a
specificity of 88%.
For women, the NGS cut-off value of 0.39 provided a sensitivity of 49% and a specificity of 65%.
For fatness parameters, the BMI cut-off value of 26.6 kg/m2 provided a sensitivity of 28% and a
specificity of 89%. The WC cut-off value of 79.4 cm provided a sensitivity of 46% and a specificity of
77%. The ROC curve for the BF% was also obtained by using a cut-off value of 32.9%, a sensitivity of
28%, and a specificity of 88%. Furthermore, the FMI cut-off value of 7.92 kg/m2 provided a sensitivity
of 40% and a specificity of 83% and the WHR cut-off value of 0.50 provided a sensitivity of 22% and a
specificity of 91%.
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Table 4. Parameters of the ROC curve analysis for the diagnostic performance of fitness and fatness parameters in identifying high cardio-metabolic risk in men
and women.
Parameters NGS BMI WC BF% FMI WHR
Men
(n = 692)
AUC (SE) 0.617 (0.022) 0.662 (0.021) 0.669 (0.021) 0.681 (0.021) 0.679 (0.021) 0.650 (0.022)
95% CI 0.580 to 0.653 0.626 to 0.697 0.632 to 0.703 0.645 to 0.715 0.643 to 0.714 0.613 to 0.685
p-value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
Cut-off 0.56 24.72 83.0 19.2 4.78 0.49
Sensitivity (95% CI) 56.86 (50.5 to 63.0) 43.36 (37.2 to 49.7) 39.37 (33.3 to 45.7) 42.58 (36.4 to 48.9) 42.97 (36.8 to 49.3) 32.68 (26.9 to 38.8)
Specificity (95% CI) 65.70 (61.1 to 70.1) 81.92 (78.0 to 85.4) 85.39 (81.8 to 88.5) 83.60 (79.8 to 86.9) 83.15 (79.3 to 86.5) 88.54 (85.2 to 91.3)
+LR (95% CI) 1.66 (1.4 to 2.0) 2.40 (1.9 to 3.1) 2.70 (2.1 to 3.5) 2.60 (2.0 to 3.3) 2.55 (2.0 to 3.3) 2.85 (2.1 to 3.9)
−LR (95% CI) 0.66 (0.6 to 0.8) 0.69 (0.6 to 0.8) 0.71 (0.6 to 0.8) 0.69 (0.6 to 0.8) 0.69 (0.6 to 0.8) 0.76 (0.7 to 0.8)
%PPV (95% CI) 48.7 (42.9 to 54.5) 57.8 (50.5 to 64.9) 60.6 (52.7 to 68.1) 59.9 (52.4 to 67.1) 59.5 (52.0 to 66.6) 61.9 (53.2 to 70.2)
%NPV (95% CI) 72.7 (68.1 to 77.0) 71.7 (67.6 to 75.5) 71.2 (67.1 to 75.0) 71.7 (67.6 to 75.5) 71.7 (67.6 to 75.6) 69.7 (65.8 to 73.5)
Women
(n = 1106)
AUC (SE) 0.664 (0.017) 0.662 (0.016) 0.653 (0.017) 0.662 (0.017) 0.664 (0.017) 0.652 (0.017)
95% CI 0.564 to 0.683 0.633 to 0.689 0.625 to 0.681 0.633 to 0.690 0.636 to 0.692 0.624 to 0.680
p-value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
Cut-off 0.39 26.61 79.40 32.90 7.92 0.50
Sensitivity (95% CI) 49.26 (44.3 to 54.2) 28.08 (23.8 to 32.7) 46.42 (41.5 to 51.4) 28.89 (24.5 to 33.6) 40.59 (35.8 to 45.6) 22.72 (18.7 to 27.1)
Specificity (95% CI) 65.50 (61.9 to 69.0) 89.86 (87.4 to 92.0) 77.33 (74.1 to 80.3) 88.41 (85.8 to 90.7) 83.08 (80.1 to 85.8) 91.38 (89.1 to 93.3)
+LR (95% CI) 1.43 (1.2 to 1.6) 2.77 (2.1 to 3.6) 2.05 (1.7 to 2.4) 2.49 (1.9 to 3.2) 2.40 (2.0 to 2.9) 2.63 (2.0 to 3.5)
−LR (95% CI) 0.77 (0.7 to 0.9) 0.80 (0.7 to 0.9) 0.69 (0.6 to 0.8) 0.80 (0.8 to 0.9) 0.72 (0.7 to 0.8) 0.85 (0.8 to 0.9)
%PPV (95% CI) 44.7 (40.1 to 49.5) 61.0 (53.6 to 68.0) 53.6 (48.2 to 58.9) 58.5 (51.3 to 65.4) 57.5 (51.6 to 63.4) 59.7 (51.5 to 67.6)
%NPV (95% CI) 69.5 (65.9 to 72.9) 68.9 (65.8 to 71.9) 71.9 (68.6 to 75.1) 68.7 (65.6 to 71.7) 71.2 (68.0 to 74.3) 67.7 (64.7 to 70.7)
NGS, normalized grip strength (Handgrip (kg)/body mass (kg)), BMI, body mass index, WC, waist circumference, BF%, Body fat percentage, FMI, fat mass index, and WHR, Waist to
height ratio. AUC: area under the curve, SE: standard error, CI: confidence interval, LR (+): positive likelihood ratio, LR (−): negative likelihood ratio, PPV: positive predictive value,
and NPV: negative predictive value.
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4. Discussion
This study investigated the relationships between muscle strength, fatness parameters, and high
cardio-metabolic risk in a large population of young Colombian adults. The findings indicate that
muscle strength and fatness parameters are both independently and jointly associated with clustered
cardio-metabolic risk, which supports the hypothesis that muscular unfitness and higher fatness
profiles are predictors of cardio-metabolic risk in early adulthood.
Muscle strength is increasingly recognized as an emerging risk factor for major causes of death
in young adulthood including cardiovascular disease [4,31,32]. Our results show that lower muscle
strength levels were independently associated with a cardio-metabolic risk profile in young adults.
This finding supports a protective effect of muscular strength on clustered cardio-metabolic risk.
Consistent with these findings, muscle fitness has been inversely associated with the lipid-metabolic
profile and metabolic syndrome risk in young people [7–11]. Similarly, Jurca et al. reported that,
in a large population of adult men, muscular strength was associated with metabolic syndrome
prevalence independently of aerobic fitness [33]. A recent longitudinal study with a 20-year follow up
in young adulthood showed that childhood muscular fitness can be used to predict adult metabolic
syndrome [12].
Therefore, this study, which is in line with the results mentioned above, supports the inclusion of
strength training in physical activity recommendations since it may provide unique cardio-metabolic
health benefits. It is possible that resistance training may confer protection against cardiovascular
risk beyond that seen for cardiorespiratory fitness. The exact mechanisms through which high
muscle fitness independently reduces cardio-metabolic risk have not been fully elucidated, but the
increased muscular fitness might produce metabolic and structural changes that improve muscle
insulin sensitivity and glycaemic control [34,35]. It has been hypothesized that the apparent protective
effect of muscular strength against high-risk clustered cardio-metabolic risk may not be a function
of maximal muscular strength but may reflect better metabolic homeostasis resulting from regular
participation in physical resistance activities [36].
In contrast, adiposity has been shown to be related to increased cardio-metabolic risk [17,23,37].
We observed that all body fatness measurements included in this study were moderately associated
with the clustered cardio-metabolic risk profile. These results are consistent with previous studies that
have reported an association between high body fatness and metabolic syndrome risk [23]. To date,
this study has examined the value of several body fatness measurements including BMI, WC, BF%,
FMI, and WHR for predicting cardio-metabolic risk in young adults. Interestingly, it should be noted
that FMI was found to be the best predictor of high cardio-metabolic risk in women. These results
indicate that, in addition to being an effective obesity screening tool [24], FMI are a useful indicator for
predicting cardio-metabolic risk in early adulthood. In line with previous studies, WC and BF% appear
to be the most important factor for predicting clustered metabolic risk in men [23]. In this sense, it was
observed that the positive predictive value in body fatness measurements was important for both sexes
(range from 48.7% to 61.9% in men and range from 44.7% to 61.0% in women, respectively), which
suggests a greater number of false positives. This positive predictive value is directly related to the
low prevalence of the highly clustered cardio-metabolic risk in the overall sample (~36%). However,
this cut-off point can only be applied to populations where the condition has a similar prevalence to
the population tested or to individuals with a similar risk of a positive result. This suggestion should
always be applied with caution in clinical practice due to population differences having a huge impact
on their interpretation.
To date, few studies have investigated the combined effect of muscular fitness and fatness since
most previous reports have focused on the combined association of muscle strength and aerobic
capacity with metabolic syndrome risk [7–10,33,38]. Our results are consistent with some recent
findings indicating that the unfit and high body fat group had the highest cardio-metabolic risk when
compared to the unfit and low body fat as well as the fit and low body fat groups. In addition, we
found that the unfit and low-fat group is less risky than the fit and high-fat group. In this context,
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a previous study demonstrated that both increased body fatness and decreased muscular strength
were associated with metabolic risk in young college students, which highlights the fact that being
physically fit can confer an added benefit on a healthy body composition [39]. Similarly, Jekal et al. [40]
found that adolescents who were in the high-fat-high-fit group had a significantly lower CVD risk
score than those who were high-fat-low-fit.
Eisenmann et al. [41] also reported that both fatness and fitness may be considered when
assessing CVD risk factors in young people especially among high-fat youth. The combined observed
associations of muscular fitness and fatness with cardio-metabolic health suggest that both indicators
may be related to common benefits. Resistance training may increase muscle quantity and insulin
action and reduce adipose tissue. Since both the predictors found in this study are modifiable,
our findings support the relevance of promoting strength training in addition to preventing body fat
accumulation to improve the cardio-metabolic health profile in young people [42].
The cut-points found in the present study were used to classify the sample by indicators of grip
strength and fatness parameters in identifying high cardio-metabolic risk. The thresholds established
to detect high risk in young people were the following: NGS ≥ 0.56 kg (men) and ≥0.39 kg (women),
BMI ≥ 24.7 kg/m2 (men), and ≥26.6 kg/m2 (women), WC ≥ 83.0 cm (men) and ≥79.4 cm (women),
BF% ≥ 19.2% (men) and ≥32.9% (women), FMI ≥ 4.78 kg/m2 (men) and ≥7.92 kg/m2 (women),
and WHR ≥ 0.49 (men) and ≥0.50 (women).
Some limitations of this study should also be addressed. First, the sample is non-probabilistic.
Second, the cross-sectional design does not allow us to explain causality. Thus, future prospective
analysis is necessary to determine causal links between the combination of muscular fitness, body
fatness, and cardio-metabolic risk. Third, muscle fitness was assessed only by measuring isometric
strength and explosive and endurance strength were not assessed. However, isometric handgrip
dynamometry is considered a reliable method for assessing strength [43]. Moreover, evidence from
the literature suggests that previous fatness cut-points were also developed by using cross-sectional
samples [24]. The indicators analyzed (BMI, WHR, and WC) are considered less accurate for estimating
body fat than densitometric or imaging techniques to identify fatness. However, such indicators
are recommended when it comes to large samples due to low operating cost and easy application.
Moreover, the combination of the five indicators used in the present study can be considered an
adequate strategy because it classified young adults as general and fatness simultaneously. Fifth,
although it should be of interest to analyze the direction of the association in a fit and low-fat group,
we have not included it in our study. Lastly, since our study population comprised a well-characterized
cohort of young Colombian adults, the results presented in this scenario may not be generalizable to
other ethnicities or age ranges.
Additional strengths of this study include the measurements of both strength and body fatness
using highly reliable measuring devices. Furthermore, it should be noted that, in this study,
several standardized fatness indicators including BMI, WC, BF%, FMI, and WHR were objectively
measured. Additionally, since we collected lifestyle factors, the muscular fitness and body fatness
analysis were extensively adjusted for relevant confounding variables including food consumption.
Lastly, highly standardized procedures have been developed within the Fuprecol study to avoid the
measurement bias.
5. Conclusions
In summary, we found that muscular strength and body fatness measurements are both
independently and jointly associated with increased cardio-metabolic risk in young adults.
This suggests that both are predictor variables related to cardio-metabolic dysfunction in young
people. These findings have clinical significance since we highlight the importance of including
muscular fitness and fatness testing in health-monitoring systems in early adulthood for the primary
prevention of metabolic disorders.
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